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Background: Vorapaxar inhibits platelet activation by antagonizing thrombin-mediated activation of the protease-activated receptor 1 on 
human platelets, and is effective for secondary prevention of cardiovascular death or ischemic events. The epidemiology of incident MI (Universal 
Classification of type & size) and the effect of vorapaxar have not previously been evaluated in patients with stable atherosclerosis.
methods: TRA 2°P-TIMI 50 was a multinational, randomized, double-blind, placebo-controlled trial of vorapaxar in 26,449 patients with prior MI, 
stroke, or peripheral arterial disease. In this analysis, all new or recurrent MIs with peak biomarker data (cTn or CKMB) were classified using the 
Universal MI Classification of size & type.
results: During a follow-up of 2.5 y, there were 1290 incident MIs of known type and size. Type 1 (spontaneous) MI’s predominated (78%, Panel 
A) with a smaller number of Type 2 (secondary, 10.2%) and Type 4 (peri-PCI, 11.9%) MI events. There was only 1 Type 3 MIs. Most MIs fell into the 
largest size class (>=10xULN). Vorapaxar showed a similar pattern of reduction in MI across the major types (HR range: 0.78 - 0.92) and size (HR 
range: 0.83 - 0.89), including a significant reduction in Type 1 MI (HR 0.82, p=0.002, Panel B) and the largest MI size class (2.9% vs. 3.3%, HR 
0.83, p=0.019).
conclusions: The most common type of incident MI in pts with stable atherosclerosis is spontaneous MI. The reduction in MI with vorapaxar was 
consistent across MIs of varying type and size.
